Tuesday, January 25, 2022
wellness India Expo

Expert Column

Here the industry leaders, policymakers, guiding lights from academia and sector experts present their individual or collective viewpoints on host of issues. This column is dedicated to their experiences with various aspects of  the bioscience landscape.

Face to Face

“We are constantly strengthening our presence in India”

263
David Schwaas, Director, Marketing & Distribution, Biopharma, Freudenberg Medical shares details about the company's business operations, product offerings, future plans and much more.

Chat with BioVoice

“We aim to grow scale across research, product lines & infrastructure”

177
Gaurav Kaushik, Managing Director & CEO, Meteoric Biopharmaceuticals says that in 2022 his company's focus will be on expanding the production capability and yield of this particular strain of probiotics..................

R&D

Events